Fig. 8From: Antitumour responses induced by a cell-based Reovirus vaccine in murine lung and melanoma modelsLevel of active virus retrieved from treated tumours approximately one week following cessation of treatment. Active virus was retrieved from both B16F10 tumours and LLC tumours that had received purified Reovirus IT. No active virus was retrieved from tumours treated with the cell-based Reovirus vaccine, either B16F10 or LLCBack to article page